One study proved that FGF21 produced by myocardial cells functions as an autocrine factor to attenuate metabolic disorder, prevent hypertrophy, and activate proinflammatory pathways in cardiac tissue [61]. This evidence concerns the gene FGF21 and metabolic disease.